1. Home
  2. TCRT vs ATXG Comparison

TCRT vs ATXG Comparison

Compare TCRT & ATXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCRT
  • ATXG
  • Stock Information
  • Founded
  • TCRT 1998
  • ATXG 2014
  • Country
  • TCRT United States
  • ATXG China
  • Employees
  • TCRT N/A
  • ATXG N/A
  • Industry
  • TCRT Biotechnology: Pharmaceutical Preparations
  • ATXG Professional Services
  • Sector
  • TCRT Health Care
  • ATXG Consumer Discretionary
  • Exchange
  • TCRT Nasdaq
  • ATXG Nasdaq
  • Market Cap
  • TCRT 3.8M
  • ATXG 3.8M
  • IPO Year
  • TCRT N/A
  • ATXG N/A
  • Fundamental
  • Price
  • TCRT $2.74
  • ATXG $0.41
  • Analyst Decision
  • TCRT
  • ATXG
  • Analyst Count
  • TCRT 0
  • ATXG 0
  • Target Price
  • TCRT N/A
  • ATXG N/A
  • AVG Volume (30 Days)
  • TCRT 58.1K
  • ATXG 523.2K
  • Earning Date
  • TCRT 08-13-2025
  • ATXG 08-13-2025
  • Dividend Yield
  • TCRT N/A
  • ATXG N/A
  • EPS Growth
  • TCRT N/A
  • ATXG N/A
  • EPS
  • TCRT N/A
  • ATXG N/A
  • Revenue
  • TCRT $11,000.00
  • ATXG $4,180,913.00
  • Revenue This Year
  • TCRT $5,680,500.00
  • ATXG N/A
  • Revenue Next Year
  • TCRT N/A
  • ATXG N/A
  • P/E Ratio
  • TCRT N/A
  • ATXG N/A
  • Revenue Growth
  • TCRT 83.33
  • ATXG N/A
  • 52 Week Low
  • TCRT $1.31
  • ATXG $0.36
  • 52 Week High
  • TCRT $6.20
  • ATXG $1.86
  • Technical
  • Relative Strength Index (RSI)
  • TCRT 34.42
  • ATXG 26.47
  • Support Level
  • TCRT $2.69
  • ATXG $0.62
  • Resistance Level
  • TCRT $3.15
  • ATXG $0.60
  • Average True Range (ATR)
  • TCRT 0.38
  • ATXG 0.06
  • MACD
  • TCRT -0.10
  • ATXG -0.02
  • Stochastic Oscillator
  • TCRT 16.00
  • ATXG 11.47

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.

About ATXG Addentax Group Corp.

Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.

Share on Social Networks: